Differentiation of semantic dementia and Alzheimer s disease using the Addenbrooke s Cognitive Examination (ACE)

Similar documents
Screening for Cognitive Dysfunction in Corticobasal Syndrome: Utility of Addenbrooke s Cognitive Examination

Piano playing skills in a patient with frontotemporal dementia: A longitudinal case study

F rontotemporal dementia (FTD) is the term currently used

How preserved is episodic memory in behavioral variant frontotemporal dementia?

This PDF is available for free download from a site hosted by Medknow Publications

I n the past three decades various cognitive screening

Mini Mental State Examination and the Addenbrooke s Cognitive Examination: Effect of education and norms for a multicultural population

CHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE

EARLY ONSET FRONTOTERMPORAL DEMENTIA AND ALZHEIMERS DISEASE: DIAGNOSIS, TREATMENT AND CARE

NEUROPSYCHOMETRIC TESTS

F rontotemporal dementia (FTD) is the most common

Differential Longitudinal Decline on the Mini-Mental State Examination in Frontotemporal Lobar Degeneration and Alzheimer Disease

Evaluation of the NINCDS-ADRDA criteria in the diverentiation of Alzheimer s disease and frontotemporal dementia

Executive function in progressive and nonprogressive behavioral variant frontotemporal dementia

Pharmacologyonline 3: (2010)

Alzheimer s Disease. Clinical characteristics of late-onset Alzheimer s disease (LOAD) A/Prof David Darby

Diagnostic criteria for dementia and Alzheimer disease

02/04/2015. The structure of the talk. Dementia as a motor disorder. Movement, cognition & behaviour. Example 1. Example 2

Received 16 February 2001; received in revised form 16 July 2001; accepted 17 July 2001

Neural Correlates of Episodic Memory in Behavioral Variant Frontotemporal Dementia

O Connor 1. Appendix e-1

Knowledge of Living and Nonliving Things in Dementia of the Alzheimer s Type

Differential diagnosis of Frontotemporal Dementia FTLD using visual rating scales

An estimated half a million

I do not have any disclosures

ORIGINAL CONTRIBUTION. Comparison of the Short Test of Mental Status and the Mini-Mental State Examination in Mild Cognitive Impairment

Alzheimer s disease dementia: a neuropsychological approach

Process of a neuropsychological assessment

Baseline Characteristics of Patients Attending the Memory Clinic Serving the South Shore of Boston

THE ROLE OF ACTIVITIES OF DAILY LIVING IN THE MCI SYNDROME

The frontotemporal dementia spectrum what the general physician needs to know Dr Jonathan Rohrer

I IADL. See Instrumental activities of daily living (IADL) Idiopathic rapid eye movement sleep behavior disorder (Idiopathic RBD), 136

ADDENBROOKE S COGNITIVE EXAMINATION ACE-R

The Impact of Dementia Severity on Caregiver Burden in Frontotemporal Dementia and Alzheimer Disease

Validity of Family History for the Diagnosis of Dementia Among Siblings of Patients With Late-onset Alzheimer s Disease

Mild cognitive impairment (MCI) is an intermediate

WHOS complex needs clients data survey: assessment and treatment options

Mild Cognitive Impairment (MCI)

Early Onset Dementia From the background to the foreground

T he cognitive profile of Alzheimer s disease has been

Brain imaging for the diagnosis of people with suspected dementia

Do not copy or distribute without permission. S. Weintraub, CNADC, NUFSM, 2009

A prospective study of dementia with Lewy bodies

Use a diagnostic neuropsychology HOW TO DO IT PRACTICAL NEUROLOGY

PLEASE SCROLL DOWN FOR ARTICLE

Dementia Past, Present and Future

The current state of healthcare for Normal Aging, Mild Cognitive Impairment, & Alzheimer s Disease

Recognition of Alzheimer s Disease: the 7 Minute Screen

NIH Public Access Author Manuscript Neurology. Author manuscript; available in PMC 2009 September 2.

Clinical phenotypes in autopsy-confirmed Pick disease

Table 7.2B: Summary of Select Screening Tools for Assessment of Vascular Cognitive Impairment in Stroke Patients

Prof Tim Anderson. Neurologist University of Otago Christchurch

Standardization and Validation of Montreal Cognitive Assessment (MoCA) in the Moroccan Population

Overview. Case #1 4/20/2012. Neuropsychological assessment of older adults: what, when and why?

Activities of Daily Living in Behavioral Variant Frontotemporal Dementia. Differences in Caregiver and Performance-based Assessments

21/05/2018. Today s webinar will answer. Presented by: Valorie O Keefe Consultant Psychologist

Service Related Project. Kimberley Keegan

Semantic Processing Ability in Persian-Speaking Alzheimer s Patients

FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS

January 18 th, 2018 Brixen, Italy

Sensitivity of current criteria for the diagnosis of behavioral variant frontotemporal dementia

Presenter Disclosure Information. I have no financial relationships to disclose:

MOTOR FUNCTION AND BEHAVIOUR ACROSS THE ALS-FTD SPECTRUM

Table 2B: Summary of Select Screening and Initial Assessment Tools for Vascular Cognitive Impairment in Stroke Patients (Updated 2014)

Objectives. Objectives continued: 3/24/2012. Copyright Do not distribute or replicate without permission 1

Comparison of clock drawing with Mini Mental State Examination as a screening test in elderly acute hospital admissions

DEMENTIA 101: WHAT IS HAPPENING IN THE BRAIN? Philip L. Rambo, PhD

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT

AGED SPECIFIC ASSESSMENT TOOLS. Anna Ciotta Senior Clinical Neuropsychologist Peninsula Mental Health Services

Frontotemporal Dementia Knowledge Scale (FTDKS) Evidence / Reference List

ORIGINAL ARTICLE Neuroscience INTRODUCTION MATERIALS AND METHODS

Quantitative analysis for a cube copying test

After the Diagnosis: Rehabilitation & Support Options for Mild Dementia

Form D1: Clinician Diagnosis

Dr Fiona Kumfor University of Sydney

Frontotemporal Dementia: Towards better diagnosis. Frontotemporal Dementia. John Hodges, NeuRA & University of New South Wales, Sydney.

Confusional state. Digit Span. Mini Mental State Examination MMSE. confusional state MRI

! slow, progressive, permanent loss of neurologic function.

Treatment of AD with Stabilized Oral NADH: Preliminary Findings

MINI-MENTAL STATE EXA MINATION (M MSE)

Cognitive Screening in Risk Assessment. Geoffrey Tremont, Ph.D. Rhode Island Hospital & Alpert Medical School of Brown University.

What is. frontotemporal. address? dementia?

Montreal Cognitive Assessment (MoCA) Overview for Best Practice in Stroke and Complex Neurological Conditions March 2013

SOCIABLE - NEXT GENERATION COGNITIVE TRAINING USING MULTI-TOUCH SURFACE COMPUTERS

Anosognosia, or loss of insight into one s cognitive

CHAPTER 2 CRITERION VALIDITY OF AN ATTENTION- DEFICIT/HYPERACTIVITY DISORDER (ADHD) SCREENING LIST FOR SCREENING ADHD IN OLDER ADULTS AGED YEARS

Erin Cullnan Research Assistant, University of Illinois at Chicago

Damian, Anne Mariam. The University of Arizona.

FTD basics! Etienne de Villers-Sidani, MD!

A semantic verbal fluency test for English- and Spanish-speaking older Mexican-Americans

The human perirhinal cortex and semantic memory

Test Assessment Description Ref. Global Deterioration Rating Scale Dementia severity Rating scale of dementia stages (2) (4) delayed recognition

Knowledge of natural kinds in semantic dementia and Alzheimer s disease q

Neuropsychological Evaluation of

The Repeatable Battery for the Assessment of Neuropsychological Status Effort Scale

Memory impairment at initial clinical presentation in posterior cortical atrophy

Screening for Normal Cognition, Mild Cognitive Impairment, and Dementia with the Korean Dementia Screening Questionnaire

Significant cognitive improvement with cholinesterase inhibition in AD with cerebral amyloid angiopathy

Thames Valley practice recommendations for the diagnosis of the Fronto-temporal Dementias

Neurodegenerative diseases that degrade regions of the brain will eventually become

Transcription:

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY Int J Geriatr Psychiatry 2008; 23: 370 375. Published online 4 September 2007 in Wiley InterScience (www.interscience.wiley.com).1887 Differentiation of semantic dementia and Alzheimer s disease using the Addenbrooke s Cognitive Examination (ACE) R. Rhys Davies 1, Kate Dawson 1, Eneida Mioshi 2, Sharon Erzinçlioğlu 2 and John R. Hodges 1,2 * 1 University of Cambridge Dept of Clinical Neurosciences, Addenbrooke s Hospital, Cambridge, UK 2 MRC Cognition and Brain Sciences Unit, Cambridge, UK SUMMARY Background The Addenbrooke s Cognitive Examination (ACE) is a simple diagnostic tool bridging the gap between the very brief Mini Mental State Exam (MMSE) and much longer test batteries used by neuropsychologists which has proven extremely popular internationally. Objective We aimed to assess the ability of the ACE to differentiate semantic dementia (SD) from Alzheimer s disease (AD). Methods The ACE was administered to three groups: SD patients (n ¼ 40) and two separate groups of AD patients (n ¼ 40 in each), matched for overall ACE or MMSE score. Results Significant differences were found between SD and both AD groups for the ACE sub-scores of naming, reading and orientation in time. Discriminant analysis (SD versus AD) led to the formulation of a semantic index (naming plus reading minus scores for serial-7s, orientation in time and drawing). Application of the semantic index to the patient data found values of less than zero to be predictive of SD rather than AD with 88% sensitivity and 90% specificity. Validation analysis in an independent sample of 24 SD and AD patients proved even more favourable. Conclusions The overall ACE score is known to be a sensitive, and specific, indicator of early neurodegenerative dementia; this study shows that the ACE can also be used to detect SD through application of the semantic index. Copyright # 2007 John Wiley & Sons, Ltd. key words semantic dementia; Alzheimer s disease; Addenbrooke s Cognitive Examination INTRODUCTION Several simple cognitive screening batteries have been devised for use in dementia patients. Such instruments aim to be brief, to cover a range of cognitive domains and to be relevant in different conditions. The Mini Mental State Exam MMSE (Folstein et al., 1975) is the most widely used and has advantages in brevity and ease of administration but lacks sensitivity (Feher et al., 1992). The Addenbrooke s Cognitive Examination (ACE) (Mathuranath et al., 2000) was developed with the aim of providing clinicians with a simple diagnostic tool to *Correspondence to: Prof. J. R. Hodges, MRC-CBU, 15 Chaucer Road, Cambridge CB2 2EF, UK. E-mail: john.hodges@mrc-cbu.cam.ac.uk Copyright # 2007 John Wiley & Sons, Ltd. bridge the gap between the MMSE and longer, comprehensive test batteries used in the evaluation of dementia (Mattis, 1988; Huppert et al., 1995). The 100-point ACE incorporates the MMSE but extends it to include tests of memory, language and executive function. It takes 10 15 min to administer and assesses six domains (orientation, attention, memory, verbal fluency, language and visuospatial function). It is more sensitive than the MMSE for the early detection of Alzheimer s disease (AD) (Mathuranath et al., 2000), can distinguish depression from dementia (Dudas et al., 2005) and can differentiate neurodegenerative syndromes including AD, frontotemporal dementia (FTD) and the Parkinsonian disorders (Mathuranath et al., 2000; Bak et al., 2005). Versions are available in several languages (Bier et al., 2004; Mathuranath et al., 2004). Received 30 March 2007 Accepted 6 July 2007

diagnosis of semantic dementia 371 Semantic dementia (SD) is a syndrome that falls within the clinical spectrum of frontotemporal dementia (FTD) (Snowden et al., 1989; Hodges et al., 1992; Garrard and Hodges, 2000). It is characterised by progressive impairment in semantic memory (our permanent store of knowledge concerning objects, people, concepts and word-meanings) with relative preservation of memory for events (episodic memory) and of other cognitive domains. SD is associated with asymmetric anterior temporal lobe atrophy, involving the left more often than the right hemisphere (Thompson et al., 2003). Recent studies have confirmed that the clinical syndrome of SD is almost always associated with the form of FTD characterised by ubiquitin-positive neuronal inclusions (Rossor et al., 2000; Davies et al., 2005). AD and SD form a double-dissociation: severely impaired semantic memory with relatively preserved episodic memory in SD and impaired episodic with preserved semantic memory in early AD (Hodges et al., 1992; Hodges and Patterson, 1995; Garrard and Hodges, 2000). Formal neuropsychological assessment easily detects the differing cognitive profiles but, for a number of reasons, brief clinical assessment may not. Firstly, patients with both AD and SD complain of poor memory and word-finding difficulty. Furthermore, reliance on word-based tests to evaluate episodic memory produces misleading results because saliency of verbal stimuli is reduced in SD, giving low scores that are not the result of true amnesia (Scahill et al., 2005). Conventional neuroimaging may also fail to distinguish between AD and SD: CT may be unremarkable in both. MRI with coronal slices shows focal anterior/inferior temporal gyral atrophy in SD relative to AD, but MRI is not always available (Galton et al., 2001; Davies et al., 2004). That SD is under-diagnosed, presumably mislabelled as AD, is suggested by the discrepancy between numbers of cases in specialist centres vs dementia services at large and also by the growing SD literature. Correct identification of dementing diseases is important for imparting information to patients and carers, and in selecting optimal pharmacotherapy. The original publication on the ACE included a comparison of AD and combined behaviour aphasic FTD group; this study assesses the diagnostic accuracy of the ACE specifically in differentiating between AD and SD. METHODS We reviewed 40 consecutive SD patients seen at the Memory Clinic between March 1997 and December 2003 to whom the ACE had been given. Scores from the first administration of the ACE were used. Nine patients had presented before the ACE was administered routinely to all clinic patients; their first ACE dated on average, 2.0 years (SD 1.3) after presentation. Patients were diagnosed according to international consensus criteria (Neary et al., 1998; McKhann et al., 2001) based upon clinical interview, extensive standard neuropsychological testing, and the findings of asymmetric anterior temporal lobe atrophy on coronal MRI. It is important to note that ACE scores were not used to make the diagnosis. We compared the ACE-profile with that in two groups of 40 AD patients diagnosed using the NINCD- S-ADRDA criteria (McKhann et al., 1984). One AD group was matched for total ACE score and the other matched for MMSE score: both were matched for sex and, as closely as possible, for age. Diagnostic inferences drawn from this analysis were tested in a new group of 12 consecutive SD patients (and 12 ACE-matched AD patients) that presented between January 2004 and March 2005. The study was approved by the Cambridge Local Research Ethics Committee. ACE testing items were grouped into twelve sub-scores: orientation in time (max ¼ 5); orientation in place (max ¼ 5); serial-7s (max ¼ 5); verbal registration (three single-words and a seven-point name and address repeated three times, max ¼ 24), verbal recall (three single-words and the seven-point address, max ¼ 10), public knowledge (max ¼ 4); lexical fluency (production of words commencing with P, max ¼ 7), category fluency (production of animal names, max ¼ 7); naming (simple line drawings, max ¼ 12); reading (orthographically regular and irregular words, max ¼ 2); other language (syntactic comprehension, repetition and sentence-writing, max ¼ 14); and drawing (overlapping pentagons, wire cube and clock-face, max ¼ 5). ACE sub-scores were compared across groups by t-tests with Bonferroni correction (SD vs ACE-matched AD, SD vs MMSEmatched AD). Discriminant analysis was performed with variables entered in a stepwise manner between the SD group and each AD group in turn. On the basis of this analysis we devised a simple arithmetic formula, the semantic index, which was then used in receiver-operator characteristic (ROC) curve analyses [area under curve with 95% Confidence Interval (CI), sensitivity and specificity quoted]. An identical ROC analysis was then undertaken for validation purposes on the independent sample of new SD and matched AD patients. Statistics were performed in SPSS10 (SPSS Inc., Chicago, IL, USA).

372 r. rhys davies ET AL. RESULTS The 40 SD patients included 25 men and 15 women and had a mean age of 62.9 7.0 years. Their mean ACE and MMSE scores were 56.7 20.3 and 22.9 5.6, respectively. Both AD groups had the same numbers of men and women but were slightly older, in keeping with the known demographics of AD; the MMSE-matched group were aged 66.7 8.8 years and the ACE-matched group were aged 67.2 7.9 years (both differing significantly from SD, p < 0.05). Mean ACE score in the MMSEmatched group was 68.3 19.9 and mean MMSE score in the ACE-matched group was 19.6 6.2, indicating the latter to be at a more advanced stage of their illness ( p < 0.05) (Table 1). Comparison of ACE sub-scores between the SD cases and the two AD groups showed significantly worse scores in SD for naming and reading (p < 0.001 for both) and significantly worse scores in AD for orientation in time ( p < 0.05) (Table 1). In addition, the MMSE-matched AD group scored significantly better than the SD group on letter and category fluency (p < 0.01, p < 0.001, respectively) and the ACE-matched AD group obtained significantly lower scores on serial-7s and drawing (p < 0.001 for both). Discriminant analysis between SD and ACEmatched AD established the key variables as naming, reading, serial-7s, orientation in time and drawing (standardised discriminant coefficients of 0.75, 0.46, 0.48, 0.35 and 0.38, respectively; 94% of cases correctly classified). The parallel analysis between SD cases and MMSE-matched AD, again highlighted reading, naming, serial-7s and orientation in time but, also, verbal recall (standardised discriminant coefficients of 0.87, 0.47, 0.46, 0.40 and 0.32, respectively; 94% of cases correctly classified). The appearance of verbal recall in the discriminant analysis was surprising, and its theoretical significance doubtful, given that mean scores for verbal recall in SD and MMSE-matched AD were identical (Table 1). The semantic index was inferred from the discriminant analyses as a numerical reflection of ACE profile: Semantic Index ¼ (naming plus reading scores) minus (serial-7s, orientation in time and drawing scores). The possible range was therefore þ14 to 15. For the SD group the mean semantic index was 6.7 4.7 while the values in AD were 3.8 3.6 (ACE-matched) and 2.5 2.8 (MMSEmatched) both significantly different from SD ( p < 0.001). ROC analyses with both MMSE-matched and ACE-matched AD groups gave highly favourable values for the diagnostic utility of the semantic index, with area under curve of 0.96 (0.92 1.0) and 0.97 (0.93 1.0), respectively. Taking zero as the cut-off correctly classified 36 of the 40 SD cases and 70 of the 80 AD cases with a sensitivity of 88% and specificity of 90% (Table 2). Applying the semantic index to an independent sample of 12 newly diagnosed SD patients and ACE-matched AD patients provided striking confirmation of its diagnostic value with an area under ROC curve of 0.99 (0.95 1.0), sensitivity 92%, and specificity 100% for a zero cut-off (Figure 1, Table 3). Table 1. Comparison of ACE sub-scores (mean standard deviation) in SD and matched AD groups SD AD (ACE-matched) AD (MMSE-matched) Orientation in place (max 5) 3.7 1.6 3.9 1.4 4.4 1.1 Orientation in date (max 5) 3.7 1.6 2.5 1.7*** 2.9 1.6* Serial-7s (max 5) 4.5 1.2 2.6 2.1*** 3.7 1.9 Registration (max 24) 15.2 6.6 13.9 6.9 17.1 7.0 Verbal recall (max 10) 2.2 3.0 1.8 2.4 2.2 2.8 Public knowledge (max 4) 0.8 1.1 1.0 1.2 1.3 1.2 Letter fluency (max 7) 3.1 1.7 3.4 2.0 4.3 2.0** Category fluency (max 7) 2.0 1.8 2.4 1.7 3.5 1.8*** Naming (max 12) 4.8 4.2 9.7 2.7*** 10.8 2.2*** Other language (max 14) 11.4 2.8 11.6 2.3 12.8 2.0 Reading (max 2) 1.1 0.5 1.6 0.6*** 1.8 0.5*** Drawing (max 5) 3.9 1.1 2.4 1.9*** 3.5 1.7 Total MMSE score (max 30) 22.9 5.6 19.6 6.2* 22.9 5.6 Total ACE score (max 100) 56.7 20.3 56.7 20.3 68.3 19.9* Semantic Index 6.7 4.7 3.8 3.6*** 2.5 2.8*** *p < 0.05. **p < 0.01. ***p < 0.001.

diagnosis of semantic dementia 373 Sensitivity 1.00-0.75-0.50-0.25-0.00 0.00 0.25 0.50 0.75 1.00 1 - Specificity Figure 1. ROC curve for the ACE-derived semantic index applied to a sample of SD and ACE-matched AD patients (n ¼ 12 per group). Table 2. Cross tabulation of semantic index with cut-off 0 for SD, MMSE-matched AD and ACE-matched AD (n ¼ 40 in each group) SD AD (ACE-matched) AD (MMSE-matched) Semantic Index <0 36 5 5 Semantic Index 0 4 35 35 Table 3. Cross tabulation of semantic index with cut-off 0 for an independent sample of SD and ACE-matched AD cases (n ¼ 12 in each group) DISCUSSION The ACE is a simple clinical tool increasingly used in the assessment of dementia (Mathuranath et al., 2000; Bak et al., 2005; Dudas et al., 2005). Total ACE score is known to be a reliable indicator of neurodegenerative dementia versus non-dementia (Mathuranath et al., 2000). This study shows that examination of the ACE profile in addition distinguishes reliably between SD and AD. Consideration of just five items from the ACE discriminated between SD and AD cases, defined on comprehensive multidisciplinary assessment, with sensitivity and specificity of about 90%. SD AD (ACE-matched) Semantic Index <0 11 0 Semantic Index 0 1 12 The key ACE sub-scores in distinguishing SD from AD were naming, reading, serial-7s, orientation in time and drawing. Naming and reading were worse in SD: naming is the most exacting test of semantic memory while surface dyslexia (mispronunciation of irregularly spelt words, e.g. pint to rhyme with hint) is a consequence of semantic impairment (Hodges et al., 1992). Both letter fluency and category fluency were significantly worse in SD than MMSE-matched AD, but neither appeared in the discriminant analysis, presumably because their discriminating power was subsumed by the naming and reading scores. Numerical and visuo-spatial skills often become impaired in AD but are typically preserved in FTD (Hodges et al., 1992); this was borne out by the higher scores for serial-7s and drawing in SD. Orientation in time was also consistently worse in AD in keeping with impaired day-to-day memory being a core AD symptom (Welsh et al., 1992); memory for events, by contrast, often seems to be preserved in SD. Interestingly, scores on the main word-based tests of attention and memory (verbal registration, verbal recall and orientation in place) were as low in SD as AD, but for different reasons. Patients with SD perform poorly on verbally based test of memory because of their degraded semantic knowledge. That is to say, they no longer fully understand the meaning of words used in such tests leading to poor encoding and retrieval (Hodges et al., 1992; Scahill et al., 2005). Similarly they are likely to fail place orientation questions due to either comprehensive or word production deficits. Scoring in SD was better on tests of attention and memory that were less challenging to the semantic system (serial-7s and orientation in time). General knowledge items, in theory, might have been easier in AD than SD but the difficulty of the task meant that scoring was near floor level in both syndromes. Other language items in the ACE consist of a range of tests of syntactic comprehension and single-word repetition not typically impaired, at presentation, in either SD or AD. Unsurprisingly, there was greater disparity between SD and the milder (MMSE-matched) AD group for the semantic items in which scoring was generally better in AD. Numerical and visuo-spatial items, by contrast, in which performance was generally stronger in SD, showed greater disparity between SD and the more advanced (ACE-matched) AD group. The need to differentiate SD and AD at varying stages, reflecting varying severity at presentation, was captured by the discriminant analysis. The resulting Semantic Index balanced semantic and visuo-spatial scores and, fortuitously, the memorable cut-off of zero gave

374 r. rhys davies ET AL. sensitivity and specificity of some 90% or greater in each of the three separate analysis undertaken (SD vs MMSE-matched AD, SD versus ACE-matched AD and new sample SD vs AD). The semantic index represents an extension and refinement of the VLOM ratio described in the original validation of the ACE (Mathuranath et al., 2002) as a method to differentiate AD from FTD. The FTD group (n ¼ 29) in the earlier study was relatively small and made up of a mixture of SD, progressive non-fluent aphasic and behavioural variant cases. Some subsequent authors have found the VLOM to have rather low specificity (Bier et al., 2004; Larner, 2005) which we suspect reflects the fact that their groups also encompassed behavioural and linguistic variants of FTD. By focusing on the SD form of FTD, the semantic index appears to have superior utility as demonstrated in the independent prospectively assessed subgroup in the study. Since the completion of this study we have revised the ACE (Mioshi et al., 2006). The ACE-R appears to have equivalent psychometric properties to the original with more precise scoring criteria and greater ease of translation into other languages. We have not yet seen a sufficiently large numbers of new SD cases to validate the semantic index in the ACE-R but our clinical experience suggests that it is equally applicable as it contains all of the elements from which the semantic index is derived. In conclusion, the ACE is highly sensitive to SD and careful observation of the profile of scores across the sub-components of the ACE, captured in the semantic index, can accurately differentiate SD from AD. It is helpful in alerting clinicians to the diagnosis of SD particularly when neuropsychological and MRI resources are limited. CONFLICT OF INTEREST None. ACKNOWLEDGEMENTS The research programmes were approved by the Human Ethics Committees of the Addenbrooke s Hospital Local Research Ethics Committee. REFERENCES Bak TH, Rogers TT, Crawford LM, et al. 2005. Cognitive bedside assesssment in atypical parkinsonian syndromes. J Neurology Neurosurg Psychiatry 76: 420 422. Bier JC, Ventura M, Donckels V, et al. 2004. Is the Addenbrooke s cognitive examination effective to detect frontotemporal dementia? J Neurology 251(4): 428 431. Davies R, Graham KS, Xuereb JH, et al. 2004. The human perirhinal cortex and semantic memory. Eur J Neurosci 20(9): 2441 2446. Davies RR, Hodges JR, Kril J, et al. 2005. The pathological basis of semantic dementia. Brain 128(9): 1985 1995. Dudas RB, Berrios GE, Hodges JR. 2005. The Addenbrooke s Cognitive Examination (ACE) in the differential diagnosis of early dementias versus affective disorder. Am J Geriatr Psychiatry 13(3): 218 226. Feher EP, Mahurin RK, Doody RS, et al. 1992. Establishing the limits of the Mini-Mental State. Examination of subtests. Arch Neurol 49: 87 92. Folstein MF, Folstein SE, McHugh PR. 1975. Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 12(3): 189 198. Galton CJ, Gomez-Anson B, Antoun N, et al. 2001. The temporal lobe rating scale: application to Alzheimer s disease and Frontotemporal dementia. J Neurology Neurosurg Psychiatry 70: 165 173. Garrard P, Hodges JR. 2000. Semantic dementia: clinical, radiological and pathological perspectives. J Neurology 247: 409 422. Hodges JR, Patterson K. 1995. Is semantic memory consistently impaired early in the course of Alzheimer s disease? Neuroanatomical and diagnostic implications. Neuropsychologia 33: 441 459. Hodges JR, Patterson K, Oxbury S, et al. 1992. Semantic dementia: progressive fluent aphasia with temporal lobe atrophy. Brain 115: 1783 1806. Huppert FA, Brayne C, Gill C, et al. 1995. CAMCOG a concise neuropsychological test to assist dementia diagnosis: sociodemographic determinants in an elderly population sample. Br J Clin Psychology 34(4): 529 541. Larner AJ. 2005. An audit of the Addenbrooke s Cognitive Examination (ACE) in clinical practice. Int J Geriatr Psychiatry 20: 593 540. Mathuranath PS, Nestor P, Berrios GE, et al. 2000. A brief cognitive test battery to differentiate Alzheimer s disease and frontotemporal dementia. Neurology 55: 1613 1620. Mathuranath DM, Hodges JR, Matthew R, et al. 2004. Adaption of the ACE for a Malayalam speaking population in Southern India. Int J Geriatr Psychiatry 19(12): 1188 1194. Mattis S. 1988. Dementia Rating Scale. Psychological Assessment Resources, Inc: Florida. McKhann G, Drachman D, Folstein M, et al. 1984. Clinical diagnosis of Alzheimer s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer s Disease. Neurology 34: 939 944. McKhann GM, Albert MS, Grossman M, et al. 2001. Clinical and pathological diagnosis of frontotemporal dementia: report of the Working Group on Frontotemporal Dementia and Pick s Disease. Arch Neurology 58: 1803 1809. Mioshi E, Dawson K, Mitchell J, et al. 2006. The Addenbrooke s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriartr Psychiatry 21: 1078 1085. Neary D, Snowden JS, Gustafson L, et al. 1998. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51: 1546 1554.

diagnosis of semantic dementia 375 Rossor MN, Revesz T, Lantos PL, et al. 2000. Semantic dementia with ubiquitin-positive tau-negative inclusion bodies. Brain 123: 267 276. Scahill VL, Hodges JH, Graham K. 2005. Can episodic memory tasks help differentiate semantic dementia from Alzheimer s disease? Neurocase 11(6): 441 451. Snowden JS, Goulding PJ, Neary D. 1989. Semantic dementia: a form of circumscribed cerebral atrophy. Behavioural Neurology 2: 167 182. Thompson SA, Patterson K, Hodges JR. 2003. Left/right asymmetry of atrophy in semantic dementia: behavioural cognitive implications. Neurology 61: 1196 1203. Welsh KA, Butters N, Hughes JP, et al. 1992. Detection and staging of dementia in Alzheimer s disease: use of the neuropsychological measures developed for the consortium to establish a registry for Alzheimer s Disease. Arch Neurology 49: 448 452.